Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Investigational New Drugs
|
January 4, 2020
A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer
Lipika Goyal, Surendra Pal Chaudhary, Eunice L Kwak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2013
Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II study
Andrew X Zhu, Marek Ancukiewicz, Jeffrey G Supko, et al.
Practical Radiation Oncology
|
June 4, 2014
Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control
Jennifer Y Wo, Stephanie K Childs, Jackie Szymonifka, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
August 30, 2020
Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized Trial
Justin C Brown, Sui Zhang, Jennifer A Ligibel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2018
A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma
Lipika Goyal, Hui Zheng, Thomas A Abrams, et al.
The Lancet. Oncology
|
November 26, 2009
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study
Andrew X Zhu, Jeffrey A Meyerhardt, Lawrence S Blaszkowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study
Andrew X Zhu, Dushyant V Sahani, Dan G Duda, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2023
G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans
Victoire Cardot-Ruffino, Naima Bollenrucher, Luisa Delius, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2023
PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer
Lestat R Ali, Patrick J Lenehan, Victoire Cardot-Ruffino, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 17, 2024
Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab
Ryan J Park, Milan Parikh, Leon Pappas, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Investigational New Drugs
|
January 4, 2020
A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer
Lipika Goyal, Surendra Pal Chaudhary, Eunice L Kwak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2013
Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II study
Andrew X Zhu, Marek Ancukiewicz, Jeffrey G Supko, et al.
Practical Radiation Oncology
|
June 4, 2014
Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control
Jennifer Y Wo, Stephanie K Childs, Jackie Szymonifka, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
August 30, 2020
Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized Trial
Justin C Brown, Sui Zhang, Jennifer A Ligibel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2018
A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma
Lipika Goyal, Hui Zheng, Thomas A Abrams, et al.
The Lancet. Oncology
|
November 26, 2009
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study
Andrew X Zhu, Jeffrey A Meyerhardt, Lawrence S Blaszkowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study
Andrew X Zhu, Dushyant V Sahani, Dan G Duda, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2023
G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans
Victoire Cardot-Ruffino, Naima Bollenrucher, Luisa Delius, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2023
PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer
Lestat R Ali, Patrick J Lenehan, Victoire Cardot-Ruffino, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 17, 2024
Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab
Ryan J Park, Milan Parikh, Leon Pappas, et al.
Page
of 5